Journal of Chest Surgery

The Korean Society for Thoracic and Cardiovascular Surgery (대한심장혈관흉부외과학회)
권호 표지

Expression of Hypoxia-inducible Factor-1 $\alpha$ in Esophageal Squamous Cell Carcinoma: Relationship to Prognosis and Tumor Biomarkers

식도 편평세포암에시 Hypoxia-inducible Factor-1 $\alpha$의 발현: 예후와 종양표지자와의 상관성

  • 양일종 (고신대학교 의과대학 흉부외과학교실) ;
  • 김종인 (고신대학교 의과대학 흉부외과학교) ;
  • 이해영 (고신대학교 의과대학 흉부외과학교) ;
  • 천봉권 (고신대학교 의과대학 병리학교) ;
  • 조성래 (고신대학교 의과대학 흉부외과학교실)
  • Published : 2004.08.01
Download PDF
⟨ Previous Next ⟩

Abstract

Background: Tissue hypoxia is a characteristic of many human malignant neoplasms, and hypoxia inducible factor-1 (HIF-1) plays a pivotal role in essential adaptive response to hypoxia, and activates a signal pathway for the expression of the hypoxia-regulated genes, resulting in increased oxygen delivery or facilitating metabolic adaptation to hypoxia. Increased level of HIF-1 a has been reported in many human malignancies, but in esophageal squamous cell carcinoma, the influence of HIF-1 a on tumor biology, including neovascularization, is not still defined. Material and Method: The influence of HIF-1 a expression on angiogenic factors, correlation between the tumor proliferation and HIF-1 a expression, interaction of HIF-1 a expression and p53, and correlation between HIF-1 a expression and clinicopathological prognostic parameters were investigated, using immunohistochemical stains for HIF-1 a, VEGF, CD34, p53, and Ki-67 on 77 cases of resected esophageal squamous cell carcinoma. Result: HIF-1 a expression in cancer cells was found in 33 of 77 esophageal squamous cell carcinoma cases. The 33 cases (42.9%) showed positive stain for HIF-1 a. High HIF-1 a expression was significantly associated with several pathological parameters, such as histologic grade (p=0.032), pathological TMN stage (p=0.002), the depth of tumor invasion (p=0.022), regional lymph node metastasis (p=0.002), distant metastasis (p=0.049), and lymphatic invasion (p=0.004). High HIF-1 a expression had significant VEGF immunoreactivity (p=0.008) and Ki-67 labeling index (p<0.001), but was not correlated with microvascular density within tumors (p=0.088). The high HIF-1 a expression was correlated with aberrant p53 accumulation with a marginal significance (p=0.056). The overall 5-year survival rate was 34.9%. The survival rate of patients with a high HIF-1 a expression was worse than that of patients with low-expression tumors (log-rank test, p=0.0001). High HIF-1 a expression was independent unfavorable factors although statistical significance is marginal in multivariate analysis. Conclusion: It is suggested that (1) high HIF-1 a expression in esophageal squamous cell carcinoma is associated with tumor hypoxia, or with genetic alteration in early carcinogenesis and progressive stages, (2) high HIF-1 a expression may be associated with intratumoral neovascularization through HIF-VEGF pathway, and (3) high HIF-1 a expression is associated with poor prognosis in patients with esophageal squamous cell carcinoma and may playa role as biomarker for regional lymph node metastasis.

배경: 악성종양에서 신생혈관 생성 및 당분해의 증가는 저산소 상태의 미세환경을 나타내며, 이는 종양의 침습성, 전이 등으로 환자의 예후와 관련이 있는 것으로 알려져 있다. Hypoxia-inducible factor 1(HIF-1)는 당원 수송체, 당분해 효소, 혈관내피세포 성장인자 등의 유전자의 전사를 활성화한다고 알려져 있다. 그리고 HIF-1의 전사 활성도는 HIF-1 a subunit의 표현이 조절되는 정도에 의존한다. 그러나 식도암에서 HIF-1의 발현과 혈관 생성능 및 종양세포 증식능과의 관계 및 예후에 관한 연구는 전무하다. 대상 및 방법: 고신대학교 의과대학 흉부외과학교실에서 1995년부터 2000년까지 수술치험한 77예의 식도 편평세포암 환자의 조직에서 채취한 정상 편평상피와 암조직에서 면역조직화학검사를 이용하여 HIF-1 a의 발현을 조사하고 혈관생성인자, 증식지수, p53 단백과의 상관관계, 임상-병리학적인 인자 및 생존율과의 상관관계를 분석하였다. 결과: HIF-1 a의 고발현율은 42.9% (33예/77예)였다. HIF-1 a의 고발현은 조직학적 등급(p=0.032), 병리학적 병기(p=0.002), 종양 침윤의 깊이(p=0.022), 주위 림프절 전이(p=0.002), 원격전이(p=0.049), 림프관 침윤(p=0.004)과 관련이 있었다. HIF-1 a의 고발현은 혈관내피세포 성장인자의 발현, Ki-67 증식지수와 관련이 있었으나, 미세혈관수와는 관련이 없었고, p53의 발현과는 관련이 있는 경향을 보였다. 단변량분석과 다변량분석에서 HIF-1 a의 고발현은 불량한 예후를 나타내는 인자로 보였다. 결론: 식도 편평세포암 조직에서 HIF-1 a의 발현은 종양조직내 신생혈관의 생성과 관련이 있는 것으로 나타났고, 고발현 된 경우는 림프절 전이와 수술 후 불량한 예후를 나타내었으므로 보다 강화된 치료전략이 필요할 것으로 사료된다.

Keywords

References

  1. Trends Biochem Sci v.24 Oncogenic alteration of metabolism Dang CV;Semenza GL https://doi.org/10.1016/S0968-0004(98)01344-9
  2. J Biol Chem v.275 Reactive oxygen species generated at mitochodrial complex Ⅲ stabilize hypoxia-inducible factor-1 alpha during hypoxia:a mechanism of O2 sensing Chandel NS;McClintock DS;Feliciano CE(et al.) https://doi.org/10.1074/jbc.M001914200
  3. Am J Physiol v.275 no.4 Temporal, spatial, and oxygen-regulated expression of hypoxia-inducible factor-1 in the lung Yu AY;Frid MG;Shimoda LA;Wiener CM;Stenmark K;Semenza GL https://doi.org/10.1152/ajpcell.1998.275.3.C818
  4. Mol Cell Biol v.16 Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1 Forsythe JA;Jiang BH;Iyer NV(et al.) https://doi.org/10.1128/MCB.16.9.4604
  5. Circ Res v.86 Hypoxic regulation of inducible nitric oxide, synthase via hypoxia inducible factor-1 in cardiac myocytes Jung F;Palmer LA;Zhou N;Johns RA https://doi.org/10.1161/01.RES.86.3.319
  6. J Biol Chem v.270 Purification and characerizaion of hypoxia-inducible factor 1 Wang GL;Semenze GL https://doi.org/10.1074/jbc.270.3.1230
  7. Blood v.92 Induction of endothelial PAS domain protein-1by hypoxia:characterization and comparison with hypoxia-inducible factor-1 alpha Wiesener MS;Turley H.;Allen WE(et al.)
  8. Cancer Res v.62 Hypoxia-inducible factors HIF-1 alpha and HIF-2 alpha in head and neck cancer: relationship to tumor biology and treatment outcome in surgically resected patients Beasley NJ;Leek R;Alam M;Turley H;Cox GJ;Gatter K
  9. Br J Cancer v.85 Relation of hypoxia inducible factor 1 alpha and 2 alpha in operable non-small cell lung cancer to angiogenic/molecular profile of tumors and survival Giatromanolaki A;Koukourakis MI;Sivridis E(et al.) https://doi.org/10.1054/bjoc.2001.2018
  10. Cancer Res v.60 Overexpression of hypoxia-inducible factor 1 alpha is a marker for an unfavorable prognosis in earlystage invasive cervical cancer Birner P;Schindl M;Obernair A;Plank C;Breitenecker G;Oberhuber G
  11. Cancer Res v.61 Hypoxia inducible factor (HIF-1a and HIF-2a)expression in early esophageal cancer and response to photodynamic therapy and radiotherapy Koukourakis MI;Giatromanolaki A;Skarlatos J(et al.)
  12. Cancer Res v.59 Overexpression of hypoxia-inducible factor 1 alpha in common human cancers and their metastases Zhong H;De Marzo,A,M.;Laughner E;Lim M;Hilton DA;Zagzag D
  13. Am J Pathol v.157 The expression and distribution of the hypoxia-inducible factors HIF-1 alpha and HIF-2 alpha in normal human tissues, cancers, and tumor-associated macrophages Talks KL;Turley H;Gatter KC(et al.) https://doi.org/10.1016/S0002-9440(10)64554-3
  14. J Biol Chem v.274 Regulation of the hypoxia-inducible transcription factor 1 alpha by the ubiquitin-proteasome pathway Kallio PJ;Wilson WJ;O'Brien S;Makino Y;Poellinger L https://doi.org/10.1074/jbc.274.10.6519
  15. Cancer Res v.59 Reciprocal positive regulation of hypoxia-inducible factor 1 alpha and insulin-like growth factor 2 Feldser D;Agani F;Iyern NV;Pak B;Ferreira G;Semenza,G.L.
  16. Cnacer Res v.60 Modulation of hypoxia-inducible factor 1 alpha expression by the epidermal growth factor /phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human postate cancer cells:implications for tumor angiogenesis and therapeutics Zhong H;Chiles K;Feldser D(et al.)
  17. Cancer Res v.57 V-SRC induces expression of hypoxia-inducible factor 1(HIF-1) and transcription of genes encoding vascular endothelial growth factor and enolase:1:involvement of HIF-1 in tumor progression Jiang BH.;Agani F;Passaniti A;Semenza GL
  18. J Natl Cancer Inst v.93 Levels of hypoxia-inducible factor-1 alpha during breast carcinogenesis Bos R;Zhong H;Hanraha CF(et al.) https://doi.org/10.1093/jnci/93.4.309
  19. World J Surg v.27 Expression of vascular endothelial growth factor as a prognostic factor in node-positive squamous cell carcinoma in the thoracic esophagus: long-term follow-up study Ogata Y;Fujita H;Yamana H;Sueyoshi S;Shirouzu K https://doi.org/10.1007/s00268-003-6866-2
  20. Cancer Res v.61 Expression of hypoxia-inducible factor-1 alpha: a novel predictive and prognostic parameter in the radiotherapy of oropharyngeal cancer Aebersold DM;Burri P;Beer KT(et al.)
  21. Int J Oncol v.17 TGF-alpha as well as VEGF, PD-ECGF and bFGF contribute to angiogenesis of esophageal squamous cell carcinoma Li Z;Shimada Y;Uchida S(et al.)
  22. Am J Gastroenterol v.96 Coexpression of vascular endothelial growth factor and p53 protein in squamous cell carcinoma of the esophagus Koide N;Nishio A;Hiraguri M;Hanazaki K;Adachi W;Amano J https://doi.org/10.1111/j.1572-0241.2001.03866.x
  23. Int J Radiat Oncol Biol Phys v.53 Hypoxia-inducible factor (HIF1A and HIF2A), angiogenesis and chamoradiotherapy outcome of squamous cell head-and-neck cancer Koukourakis MI;Giatromanolaki A;Sivridis E(et al.) https://doi.org/10.1016/S0360-3016(02)02848-1
  24. J Korean Med Sci v.17 Clinical prognostic values of vascular endothelial growth factor, microvessel density, and p53 expression in esophageal carcinomas Ahn,M.J.;Jang,S.J.;Park,Y.W.(et al.) https://doi.org/10.3346/jkms.2002.17.2.201
  25. Br J Cancer v.86 Expression of angiogenic factors predicts response to chemoradiotherapy and prognosis of oesophageal squamous cell carcinoma Shimada H;Hoshino T;Okazumi S;Matsubara H;Funami Y https://doi.org/10.1038/sj.bjc.6600129